I agree that this site is using cookies. You can find further informations here.
X
de Jonge, Maja J. A.
248  results:
Search for persons X
?
1

Comprehensive characterization of circulating tumor cells a..:

Bos, Manouk K. ; Kraan, Jaco ; Starmans, Martijn P. A....
Molecular Oncology.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

The development of brain metastases in patients with differ..:

Derks, Sophie H. A. E. ; van der Meer, Edgar L. ; Joosse, Arjen...
International Journal of Cancer.  155 (2024)  6 - p. 1045-1052 , 2024
Link: https://doi.org/10.1002/..
 
?
3

First-in-human study of naporafenib (LXH254) with or withou..:

Janku, Filip ; Kim, Tae Min ; Iyer, Gopakumar...
European Journal of Cancer.  196 (2024)  - p. 113458 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Patient values in patient-provider communication about part..:

van Lent, Liza G. G. ; van der Ham, Mirte ; de Jonge, Maja J. A....
BMC Medical Informatics and Decision Making.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Olaparib and durvalumab in patients with relapsed small cel..:

Krebs, Matthew G. ; Delord, Jean-Pierre ; Jeffry Evans, Thomas R....
Lung Cancer.  180 (2023)  - p. 107216 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Impact of Novel Treatments in Patients with Melanoma Brain ..:

Derks, Sophie H. A. E. ; Jongen, Joost L. M. ; van der Meer, Edgar L....
Cancers.  15 (2023)  5 - p. 1461 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Dabrafenib plus trametinib in patients with relapsed/refrac..:

Kreitman, Robert J. ; Moreau, Philippe ; Ravandi, Farhad...
Blood.  141 (2023)  9 - p. 996-1006 , 2023
Link: https://doi.org/10.1182/..
 
?
8

NCMP-01. TREATMENT STRATEGIES IN PATIENTS WITH RENAL CELL C..:

Derks, Sophie ; van der Meer, Edgar ; Joosse, Arjen...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v206-v207 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancer..:

Subbiah, Vivek ; Kreitman, Robert J. ; Wainberg, Zev A....
Nature Medicine.  29 (2023)  5 - p. 1103-1112 , 2023
Link: https://doi.org/10.1038/..
 
?
10

Efficacy, safety and biomarker analysis of durvalumab in pa..:

Geurts, Birgit S. ; Battaglia, Thomas W. ; van Berge Henegouwen, J. Maxime...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
11

Olaparib plus Durvalumab, with or without Bevacizumab, as T..:

Drew, Yvette ; Kim, Jae-Weon ; Penson, Richard T....
Clinical Cancer Research.  30 (2023)  1 - p. 50-62 , 2023
Link: https://doi.org/10.1158/..
 
?
12

Pharmacokinetics and immunogenicity of eftozanermin alfa in..:

Biesdorf, Carla ; Guan, Xiaowen ; Siddani, Satya R....
Cancer Chemotherapy and Pharmacology.  , 2023
Link: https://doi.org/10.1007/..
 
?
13

Trotabresib (CC-90010) in combination with adjuvant temozol..:

Vieito, Maria ; Simonelli, Matteo ; de Vos, Filip...
Neuro-Oncology Advances.  4 (2022)  1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

Decisional Conflict after Deciding on Potential Participati..:

van Lent, Liza G. G. ; de Jonge, Maja J. A. ; van der Ham, Mirte...
Cancers.  14 (2022)  6 - p. 1500 , 2022
Link: https://doi.org/10.3390/..
 
?
15

Core values of patients with advanced cancer considering pa..:

van Gurp, Jelle L. P. ; van Lent, Liza G. G. ; Stoel, Nicole...
Supportive Care in Cancer.  30 (2022)  9 - p. 7605-7613 , 2022
Link: https://doi.org/10.1007/..
 
1-15